Clinical trial

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

NCT06763081

Study summary

ClinicalTrials.gov

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Not applicable- observational study Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-03-01

PhaseN/A

Conditions

Behavioral Activationunresolved

Major Depressive Disorderverified · MONDO: major depressive disorder

Anxiety Disordersunresolved

Antidepressant Drug Adverse Reactionunresolved

Obsessive Compulsive Disorder (OCD)unresolved

Major Depressionverified · MONDO: major depressive disorder

Interventions

Not applicable- observational studyOTHER

Sponsors & collaborators

University of Manitobalead sponsor

Health Sciences Centre Foundation, Manitobacollaborator

Children's Hospital Research Institute of Manitobacollaborator

University of Calgarycollaborator

Mapped research locations

WinnipegManitoba, Canada2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06763081 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.